SHR-1816

N/A

Report date: 2025/02/21 16:57:15

Base Information

Drug NameSHR-1816
Drug Alias NameSHR1816SHR-1816
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGlucagon receptor agonistsGlucagon-like peptide 1 receptor agonists
TargetsGlucagon receptorGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Suncadia Medicine Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Suncadia Medicine Co Ltd
Inactive CompaniesShanghai Hengrui Pharmaceutical Co Ltd
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A